ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men.


Introduction Angiotensin II, a major effector protein of the renin angiotensin system (RAS), induces bone loss under certain conditions. Drugs that block the RAS may therefore reduce bone loss and fracture incidence. The fracture incidence in older hypertensive men with long-term use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor… (More)
DOI: 10.1093/ageing/afw150


3 Figures and Tables